Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $43.1000 (-2.71%) ($41.7000 - $44.6000) on Wed. Oct. 7, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.11% (three month average) | RSI | 56 | Latest Price | $43.1000(-2.71%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 1.2% a day on average for past five trading days. | Weekly Trend | CAPR declines -1.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) SKYY(8%) VT(7%) XLF(7%) EWG(6%) EWI(6%) | Factors Impacting CAPR price | CAPR will decline at least -2.055% in a week (0% probabilities). VIXM(-5%) TLT(-5%) SHY(-3%) GLD(-3%) BND(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.055% (StdDev 4.11%) | Hourly BBV | 0 () | Intraday Trend | -2.9% | | | |
|
5 Day Moving Average | $42.94(0.37%) | 10 Day Moving Average | $42(2.62%) | 20 Day Moving Average | $42.47(1.48%) | To recent high | -15.5% | To recent low | 11.7% | Market Cap | $849m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |